GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Market Cap

Astellas Pharma (Astellas Pharma) Market Cap : $17,228 Mil (As of Apr. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Astellas Pharma's share price for the quarter that ended in Dec. 2023 was $11.9. Astellas Pharma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,793 Mil. Therefore, Astellas Pharma's market cap for the quarter that ended in Dec. 2023 was $21,337 Mil.

Astellas Pharma's quarterly market cap declined from Jun. 2023 ($26,718 Mil) to Sep. 2023 ($24,885 Mil) and declined from Sep. 2023 ($24,885 Mil) to Dec. 2023 ($21,337 Mil).

Astellas Pharma's annual market cap declined from Mar. 2021 ($28,611 Mil) to Mar. 2022 ($28,466 Mil) and declined from Mar. 2022 ($28,466 Mil) to Mar. 2023 ($25,505 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Astellas Pharma's Enterprise Value for Today is $21,053 Mil.


Astellas Pharma Market Cap Historical Data

The historical data trend for Astellas Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Market Cap Chart

Astellas Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,231.02 28,308.45 28,610.78 28,465.75 25,505.01

Astellas Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27,698.38 25,505.01 26,717.82 24,885.13 21,336.58

Competitive Comparison of Astellas Pharma's Market Cap

For the Drug Manufacturers - General subindustry, Astellas Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astellas Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Market Cap falls into.



Astellas Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Astellas Pharma's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=$14.195*1796.76
=$25,505

Astellas Pharma's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$11.9*1792.99
=$21,337

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Astellas Pharma  (OTCPK:ALPMY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Astellas Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Astellas Pharma (Astellas Pharma) Business Description

Traded in Other Exchanges
Address
2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411
Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (Astellas Pharma) Headlines

From GuruFocus

Astellas to Acquire Propella Therapeutics

By PRNewswire 11-16-2023